Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms
Small Science, Volume 5, Issue 11, November 2025.This review highlights recent advances in engineering extracellular vesicles (EVs) as next‐generation cancer vaccines. It outlines their biological roles and antigen‐presenting capacity, explores key strategies for antigen loading and delivery optimization, and summarizes preclinical and clinical applications using EVs from diverse immune and tumor ...
Wonkyung Ahn +4 more
wiley +1 more source
Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy. [PDF]
, 2016 Patient-derived xenograft (PDX) mouse models of cancer are emerging as an important component of personalized precision cancer therapy. However, most models currently offered to patients have their tumors subcutaneously-transplanted in immunodeficient ...
Bouvet, Michael +10 more
core +2 more sources
Benign multicystic peritoneal mesothelioma: a case report
Journal of Medical Case Reports, 2010 Introduction We report the case of a patient with a benign multicystic peritoneal mesothelioma and describe its appearance on computed tomography scans and ultrasonography, in correlation with gross clinical and pathological findings. Case presentation A
Papapaulou Leonidas +7 more
doaj +1 more source
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]
, 2017 Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele +9 more
core +1 more source
Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study [PDF]
, 2021 Odd Terje Brustugun +2 more
openalex +1 more source
PERITONEAL MESOTHELIOMA AS A CO-MALIGNANCY IN A PATIENT WITH CLL/SLL: CASE REPORT
Hematology, Transfusion and Cell TherapyObjective: Malignant mesothelioma (MM) is an aggressive tumor typically arising from the pleura, with malignant peritoneal mesothelioma (MPM) accounting for 10-15% of cases. The occurrence of MPM alongside hematologic malignancies is rare.
Satı Betül Beydilli +3 more
doaj +1 more source
Clinical Case Reports, 2020 Mesothelioma is a rare tumor usually located on the pleura. In this typical location, it is closely linked to asbestos exposure. However, in other locations such as in peritoneal mesothelioma, the association to asbestos remains unusual.
Dorra Brahim +5 more
doaj +1 more source
Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]
, 2019 Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica +8 more
core +1 more source
Florid diffuse peritoneal deciduosis mimicking carcinomatosis in a primigravida patient: A case report and review of the literature [PDF]
, 2013 A case of a 27 year old G1P0 female with a dichorionic, diamniotic twin pregnancy presenting with premature rupture of membranes found to have omental caking and diffuse yellow-tan peritoneal nodules, clinically suspicious for carcinomatosis.
Adhikari, Laura J, Shen, Rulong
core +2 more sources